Data / Research funding / Tennessee / University of Tennessee Health Sci CTR
University of Tennessee Health Sci CTR: 207 NIH awards ($269.3M) and 1 NSF award ($159K), fiscal years 2021 to 2026
University of Tennessee Health Sci CTR in Memphis, TN is funded under 207 NIH awards ($269.3M) and 1 NSF award ($159K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- X1M1PN3KG3E7
- State
- Tennessee
Awards
208 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Center of Excellence for Encephalitic Alphavirus Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $14,845,948 | March 6, 2019 | February 28, 2026 | JONSSON, COLLEEN B | reporter.nih.gov |
| Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $7,110,816 | August 18, 2023 | July 31, 2028 | JONSSON, COLLEEN B | reporter.nih.gov |
| Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,121,279 | February 1, 2021 | January 31, 2027 | WILLIAMS, ROBERT W. | reporter.nih.gov |
| UTHSC RBL Administrative Supplement For Antiviral Discovery & Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $5,233,648 | September 15, 2021 | February 28, 2025 | JONSSON, COLLEEN B | reporter.nih.gov |
| Novel Extended Release Glaucoma Therapy for Once Daily Dosing | NIH | National Eye Institute | 2021 to 2024 | $4,201,359 | March 1, 2020 | February 28, 2026 | JABLONSKI, MONICA M | reporter.nih.gov |
| Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk. | NIH | National Cancer Institute | 2022 to 2025 | $4,079,710 | September 1, 2022 | August 31, 2027 | MAKOWSKI-HAYES, LIZA | reporter.nih.gov |
| Genetics of oxycodone intake in a hybrid rat diversity panel. | NIH | National Institute on Drug Abuse | 2021 to 2025 | $3,392,750 | April 15, 2021 | January 31, 2027 | SHARP, BURT M | reporter.nih.gov |
| Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,193,450 | September 10, 2021 | August 31, 2026 | ATAGA, KENNETH I | reporter.nih.gov |
| Radiobiology Research Suite Expansion of the TriMetis GLP Vivarium at UTHSC | NIH | Office of the Director, National Institutes of Health | 2021 | $3,115,346 | September 20, 2021 | July 31, 2023 | TIGYI, GABOR J | reporter.nih.gov |
| Small molecule enhancers of tumor immunity targeting the LPA5 GPCR | NIH | National Cancer Institute | 2022 to 2025 | $3,114,085 | August 1, 2022 | July 31, 2026 | TIGYI, GABOR J | reporter.nih.gov |
| Mapping genetic vulnerability to oxidative stress in development and its consequences in age-associated cognitive decline using a novel reduced complexity rat model | NIH | National Institute on Aging | 2025 | $3,078,607 | September 1, 2025 | August 31, 2029 | MULLIGAN, MEGAN KATHLEEN | reporter.nih.gov |
| Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes | NIH | National Institute on Aging | 2021 to 2025 | $3,069,231 | September 30, 2021 | May 31, 2027 | ZHAO, QI | reporter.nih.gov |
| Antifungal antagonism as a cause of treatment failure for invasive mycoses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,062,575 | April 1, 2021 | March 31, 2027 | PALMER, GLEN | reporter.nih.gov |
| Mitoprotective therapies for kidney injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,010,432 | September 15, 2025 | August 31, 2029 | BAJWA, AMANDEEP | reporter.nih.gov |
| Retaining the diverse CANDLE cohort to advance ECHO Cohort solution-oriented research and identify early-life modifiable risk factors for obesity and mental health problems in children | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $2,917,689 | September 1, 2023 | May 31, 2025 | ZHAO, QI | reporter.nih.gov |
| Angiotensins, Prostaglandins and Adrenergic Interactions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,917,328 | September 1, 1977 | March 31, 2027 | MALIK, KAFAIT U | reporter.nih.gov |
| Genetics of epigenetic response to high circulating glucocorticoids and organophosphorus compounds | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,847,347 | April 1, 2021 | January 31, 2027 | JONES, BYRON C | reporter.nih.gov |
| Virtual Patient Cohorts to Illuminate Immunologic Drivers of Influenza Severity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,844,812 | June 1, 2022 | May 31, 2027 | SMITH, AMBER M | reporter.nih.gov |
| Pain Sensitivity and Unpleasantness in People with Alzheimer's Disease and Cancer | NIH | National Institute on Aging | 2021 to 2023 | $2,659,054 | August 15, 2019 | May 31, 2026 | COWAN, RONALD L | reporter.nih.gov |
| Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,634,208 | March 1, 2020 | February 28, 2026 | FORTWENDEL, JARROD R. | reporter.nih.gov |
| Life Stress Pathways and Resilience to Substance Misuse in Black and White Youth | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,553,715 | September 1, 2022 | June 30, 2027 | DEREFINKO, KAREN J | reporter.nih.gov |
| SK3 channel trafficking in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,531,115 | July 1, 2021 | April 30, 2026 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk | NIH | National Cancer Institute | 2022 to 2025 | $2,511,526 | January 14, 2022 | December 31, 2026 | JOHNSON, KAREN C | reporter.nih.gov |
| Fetal cerebral arteries and prenatal alcohol exposure | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,492,106 | March 15, 2022 | January 31, 2027 | BUKIYA, ANNA | reporter.nih.gov |
| Testing the Effects of Contingency Management and Behavioral Economics on Buprenorphine-Naloxone Treatment Adherence Using a Sequential Multiple Assignment Randomized Trial (SMART) Design | NIH | National Center for Complementary & Integrative Health | 2021 | $2,477,571 | September 28, 2019 | September 19, 2025 | DEREFINKO, KAREN J | reporter.nih.gov |
| PKD proteins in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,397,306 | February 15, 2021 | January 31, 2026 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Dissecting the neurobiological basis of social control over alcohol self-administration | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $2,365,880 | September 25, 2025 | August 31, 2029 | TUNSTALL, BRENDAN | reporter.nih.gov |
| The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity | NIH | National Institute on Aging | 2022 to 2025 | $2,351,681 | February 1, 2022 | November 30, 2026 | ASHBROOK, DAVID GEORGE | reporter.nih.gov |
| Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses | NIH | National Eye Institute | 2021 to 2025 | $2,328,731 | January 1, 2021 | December 31, 2026 | VAITHIANATHAN, THIRUMALINI | reporter.nih.gov |
| Unlocking the cidal activity of echinocandins against Aspergillus fumigatus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,283,080 | April 1, 2021 | March 31, 2027 | FORTWENDEL, JARROD R. | reporter.nih.gov |
| Identification of gene variants mediating the behavioral and physiological response to THC | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,243,926 | July 1, 2023 | April 30, 2028 | MULLIGAN, MEGAN KATHLEEN | reporter.nih.gov |
| Prenatal Longitudinal Metabolomics Profiling for Early Childhood Growth Trajectories and Obesity Risk in a US Biracial Birth Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,228,767 | April 1, 2023 | March 31, 2028 | ZHAO, QI | reporter.nih.gov |
| Circulating microbiome and premature mortality in hemodialysis patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,165,649 | July 1, 2020 | February 28, 2026 | SUMIDA, KEIICHI | reporter.nih.gov |
| Validation of a novel tau clearance mechanism. | NIH | National Institute on Aging | 2022 | $2,157,183 | June 1, 2022 | May 31, 2025 | LIAO, FRANCESCA-FANG | reporter.nih.gov |
| Ethanol actions on slo channels from arteries vs. brain. | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,133,769 | January 1, 1999 | August 31, 2027 | DOPICO, ALEX | reporter.nih.gov |
| Radiation-Induced Paneth Cell Dysfunction | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,133,250 | August 18, 2022 | May 31, 2027 | RAO, RADHAKRISHNA | reporter.nih.gov |
| Study Title: Pharmacy-led Transitions of Care Intervention to Address System-Level Challenges and Improve Medication Adherence in Low-Income Populations | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,127,501 | July 6, 2023 | January 31, 2028 | SURBHI, SATYA | reporter.nih.gov |
| Role of microbially-derived metabolites in anti-tumor immunity in breast cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,124,146 | August 1, 2020 | August 31, 2030 | MAKOWSKI-HAYES, LIZA | reporter.nih.gov |
| Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer | NIH | National Cancer Institute | 2021 to 2024 | $2,117,272 | July 28, 2020 | June 30, 2026 | LI, WEI | reporter.nih.gov |
| Pangenomics of nicotine abuse in the hybrid rat diversity panel | NIH | National Institute on Drug Abuse | 2023 to 2025 | $2,073,805 | September 1, 2023 | June 30, 2028 | SHARP, BURT M | reporter.nih.gov |
| Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage. | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $2,001,739 | March 15, 2022 | February 28, 2027 | RAO, RADHAKRISHNA | reporter.nih.gov |
| Ceramides and Sphingolipids as Predictors of Incident Dysglycemia | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,979,895 | March 1, 2021 | February 28, 2026 | DAGOGO-JACK, M.D., D.SC., SAMUEL | reporter.nih.gov |
| Blood-brain-barrier and white matter mechanisms underlying dementia | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,967,005 | February 1, 2021 | January 31, 2024 | LIAO, FRANCESCA-FANG | reporter.nih.gov |
| System genetics of menthol and nicotine addiction | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,935,481 | April 1, 2019 | December 31, 2024 | CHEN, HAO | reporter.nih.gov |
| Targeting the colchicine binding site in tubulin for cancer therapy | NIH | National Cancer Institute | 2021 to 2025 | $1,935,287 | January 1, 2011 | December 31, 2026 | LI, WEI | reporter.nih.gov |
| Making Healthy Habits Stick: Extended Contact Interventions to Promote Long-Term Physical Activity in Cancer Survivors | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,926,812 | September 21, 2023 | March 31, 2028 | MARTIN, MICHELLE | reporter.nih.gov |
| Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligence | NIH | National Eye Institute | 2022 to 2025 | $1,898,340 | April 1, 2022 | August 4, 2025 | YOUSEFI, SIAMAK | reporter.nih.gov |
| Discovery of modifier genes in cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,888,665 | April 1, 2020 | March 31, 2025 | TOWBIN, JEFFREY ALLEN | reporter.nih.gov |
| Chloride channels in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,870,108 | March 1, 2023 | February 28, 2027 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Cholinergic modulation of olfactory coding. | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $1,848,146 | March 1, 2015 | May 31, 2027 | FLETCHER, MAX L | reporter.nih.gov |
| Targeting brain and bone metastases in metastatic breast cancer for improved patient survival | NIH | National Cancer Institute | 2023 to 2025 | $1,813,940 | April 20, 2023 | March 31, 2028 | LI, WEI | reporter.nih.gov |
| Development of a Theranostic Immunotherapy for Systemic Amyloidosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,776,696 | March 1, 2021 | February 28, 2026 | WALL, JONATHAN S | reporter.nih.gov |
| Ionic mechanisms of toluene cerebrovascular actions | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,753,722 | May 25, 2022 | February 28, 2027 | DOPICO, ALEX | reporter.nih.gov |
| A Unified High Performance Web Service for Systems Genetics and Precision Medicine | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,738,407 | April 15, 2017 | June 30, 2025 | SEN, SAUNAK | reporter.nih.gov |
| Algorithm-based prevention and reduction of differences in cancer outcomes arising from data imbalance | NIH | National Cancer Institute | 2021 to 2025 | $1,729,672 | September 1, 2021 | August 31, 2027 | CUI, YAN | reporter.nih.gov |
| Cholesterol regulation of smooth muscle BK channel proteins and consequent control of cerebral artery diameter | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,725,030 | July 1, 2020 | June 30, 2025 | DOPICO, ALEX M. | reporter.nih.gov |
| Identification of Metabolomic Profiles for Sarcopenia Traits in Older Whites and Blacks | NIH | National Institute on Aging | 2021 to 2023 | $1,718,289 | September 1, 2019 | April 30, 2025 | ZHAO, QI | reporter.nih.gov |
| Nf2-dependent regulation of neuronal scaling in the developing cerebellum | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,692,665 | June 15, 2022 | May 31, 2027 | CHIZHIKOV, VIKTOR | reporter.nih.gov |
| Investigation into Arterial Stiffness and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,686,481 | September 1, 2020 | August 31, 2025 | SUN, ZHONGJIE | reporter.nih.gov |
| Novel Degraders of the Androgen Receptor (AR) and AR Splice Variants (AR-SVs) | NIH | National Cancer Institute | 2021 to 2023 | $1,653,777 | February 1, 2019 | January 31, 2025 | NARAYANAN, RAMESH | reporter.nih.gov |
| Vascular ion channels and microcirculation in neonatal urinary tract obstruction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,646,127 | May 1, 2020 | January 31, 2024 | ADEBIYI, ADEBOWALE | reporter.nih.gov |
| Building Tools and Community to Make Pangenomes Accessible | NIH | National Human Genome Research Institute | 2024 | $1,645,076 | September 19, 2024 | August 31, 2027 | GARRISON, ERIK | reporter.nih.gov |
| Investigations into the Etiology of Phantom Limb Sensations and Phantom Limb Pain | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,622,647 | September 17, 2018 | April 30, 2025 | WATERS, ROBERT S | reporter.nih.gov |
| Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | NIH | National Cancer Institute | 2022 to 2025 | $1,610,773 | February 15, 2022 | January 31, 2027 | MAKOWSKI-HAYES, LIZA | reporter.nih.gov |
| Fungal-bacterial dynamics driving dysregulated host responses and lethal synergism | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,608,527 | July 15, 2024 | June 30, 2029 | PETERS, BRIAN M | reporter.nih.gov |
| The Neural Organization of Taste Neophobia | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $1,540,000 | August 2, 2022 | July 31, 2027 | BOUGHTER, JOHN D | reporter.nih.gov |
| GRP78 signaling and retinal angiogenesis | NIH | National Eye Institute | 2023 to 2025 | $1,533,198 | August 1, 2023 | February 28, 2027 | RAO, GADIPARTHI N | reporter.nih.gov |
| Chloride channels in diabetic vascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,520,000 | December 1, 2019 | November 30, 2025 | LEO, M. DENNIS MARCUS | reporter.nih.gov |
| Therapeutic targeting of the SWI/SNF chromatin remodeler to regulate GBM chemosensitivity | NIH | National Cancer Institute | 2023 to 2025 | $1,499,435 | July 15, 2023 | June 30, 2028 | PFEFFER, LAWRENCE MARC | reporter.nih.gov |
| Adipose T cell microRNAs (miRs) regulate macrophage function during obesity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,497,037 | February 1, 2020 | January 31, 2027 | SINGH, UDAI P. | reporter.nih.gov |
| Genetic and Environmental Determinants of GPRC6A Regulation of Energy Metabolism Using Genetically Engineered Mice and Systems Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,487,562 | January 1, 2020 | December 31, 2024 | PI, MIN | reporter.nih.gov |
| Mitigation of GI-ARS by Lactobacillus species | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,458,632 | December 22, 2022 | November 30, 2027 | RAO, RADHAKRISHNA | reporter.nih.gov |
| Addressing Collagen Mediated Protection of Systemic Amyloid Fibrils | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,453,973 | September 9, 2024 | August 31, 2028 | JACKSON, JOSEPH WILSON | reporter.nih.gov |
| Rectifying Disparities Associated with Risk Score-Based MTM Eligibility in Enhanced MTM | NIH | National Institute on Aging | 2021 to 2025 | $1,411,142 | September 1, 2011 | April 30, 2028 | WANG, JUNLING NONE | reporter.nih.gov |
| Sphingolipids and their Impact in Corneal Wound Healing | NIH | National Eye Institute | 2021 to 2023 | $1,405,661 | July 1, 2020 | May 31, 2025 | MANDAL, NAWAJES | reporter.nih.gov |
| Inflammatory regulation of epileptogenesis after status epilepticus | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $1,396,500 | August 3, 2018 | November 30, 2028 | JIANG, JIANXIONG | reporter.nih.gov |
| Reduced complexity mapping of oxycodone self-administration and stress responsiveness in rats | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,379,892 | May 1, 2020 | February 28, 2026 | CHEN, HAO | reporter.nih.gov |
| Epigenetic Regulation of Kidney Function and Blood Pressure | NIH | National Institute on Aging | 2021 to 2023 | $1,353,364 | May 1, 2019 | February 28, 2026 | SUN, ZHONGJIE | reporter.nih.gov |
| Control of microvascular function by ion channels | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,349,357 | April 1, 2020 | June 30, 2023 | ADEBIYI, ADEBOWALE | reporter.nih.gov |
| Human pregnane X receptor and sexual dimorphism in alcoholic liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $1,333,128 | May 1, 2022 | June 30, 2025 | GYAMFI, MAXWELL AFARI | reporter.nih.gov |
| Genetics of stroke vulnerability in C57BL/6 mouse substrains | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,291,256 | July 15, 2020 | June 30, 2025 | NOWAK, THADDEUS S. | reporter.nih.gov |
| Candidalysin: a key mediator of Candida vaginitis immunopathology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,283,145 | February 1, 2024 | December 31, 2028 | PETERS, BRIAN M | reporter.nih.gov |
| Development of first-in-class ST2 inhibitors for treating graft-versus-host disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,269,807 | June 6, 2019 | January 31, 2024 | YANG, CHAO-YIE | reporter.nih.gov |
| Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,232,000 | July 1, 2022 | June 30, 2027 | LARIBEE, RONALD | reporter.nih.gov |
| Dysbiosis in Hirschsprung Associated Enterocolitis Pathogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,224,406 | April 1, 2020 | January 31, 2024 | GOSAIN, ANKUSH | reporter.nih.gov |
| Regulation of kidney function and blood pressure in aging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,214,215 | April 1, 2024 | March 31, 2028 | SUN, ZHONGJIE | reporter.nih.gov |
| The role of UBE3A in gliopathic seizures | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,212,391 | September 30, 2020 | August 2, 2024 | REITER, LAWRENCE T | reporter.nih.gov |
| Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,200,610 | March 20, 2019 | January 31, 2026 | DOPICO, ALEX M. | reporter.nih.gov |
| Urotensin II and renal insufficiency in growth-restricted infants. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,192,324 | September 15, 2020 | August 31, 2025 | ADEBIYI, ADEBOWALE | reporter.nih.gov |
| Pathways to Improving Breast Health Outcomes in Neighborhoods with Concentrated Poverty | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,126,650 | August 29, 2023 | February 28, 2027 | WHITE-MEANS, SHELLEY | reporter.nih.gov |
| From High School to Health Care: Lab and Data Science Pathways for Success | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,039,181 | August 5, 2022 | June 30, 2027 | MOORE, JACEN SHANNON | reporter.nih.gov |
| Blood-brain-barrier and white matter mechanisms underlying dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,032,543 | February 1, 2021 | January 31, 2027 | LIAO, FRANCESCA-FANG | reporter.nih.gov |
| Mechanisms of Altered Gastrointestinal Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,026,000 | September 15, 2013 | April 30, 2026 | VERNE, GEORGE NICHOLAS | reporter.nih.gov |
| Retaining the CANDLE cohort to advance ECHO Cohort solution-oriented research and identify early-life modifiable risk factors for obesity and mental health problems in children | NIH | Office of the Director, National Institutes of Health | 2025 | $1,001,793 | September 1, 2023 | May 31, 2030 | ZHAO, QI | reporter.nih.gov |
| Neonatal cerebral vascular injury by prolonged asphyxia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $997,190 | July 1, 2024 | June 30, 2029 | PARFENOVA, HELENA | reporter.nih.gov |
| Resolving Racial/Ethnic Disparities Associated with Star Ratings among the ADRD Population | NIH | National Institute on Aging | 2021 to 2022 | $967,840 | August 15, 2015 | June 30, 2023 | WANG, JUNLING NONE | reporter.nih.gov |
| MiR-204 regulates type 1 IP3R/Ca2+ axis to control vascular smooth muscle cell contractility and blood pressure: Potential role of the gut microbiome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $938,542 | September 1, 2020 | June 30, 2023 | KASSAN, MODAR O. | reporter.nih.gov |
| Dynamics of Kv channel function in identified populations of pyramidal neurons in neocortex | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $933,513 | March 1, 2003 | January 31, 2024 | FOEHRING, ROBERT C | reporter.nih.gov |
| The molecular mechanism of Siglec-E in bacterial clearance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $924,000 | June 13, 2024 | April 30, 2029 | CHEN, GUOYUN | reporter.nih.gov |
| The role of long non-coding RNA GAS5 in diabetic wounds | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $923,334 | May 1, 2019 | April 30, 2024 | XU, JUNWANG | reporter.nih.gov |
| Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia - The "NONO trial" - a pragmatic, multi-center, de-implementation, stepped-wedge, cluster-randomized trial | NIH | National Heart, Lung, and Blood Institute | 2024 | $915,604 | September 17, 2024 | July 31, 2025 | JANCELEWICZ, TIMOTHY | reporter.nih.gov |
| Optimization of Novel Small Molecules to Antagonize FGF-23 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $912,000 | July 1, 2019 | August 31, 2024 | XIAO, ZHOUSHENG | reporter.nih.gov |
| ZerO Degree head positioning In Acute ischemiC stroke (ZODIAC) | NIH | National Institute of Nursing Research | 2021 to 2023 | $901,725 | September 25, 2018 | June 30, 2024 | ALEXANDROV, ANNE W | reporter.nih.gov |
| Clinical, Biochemical, and Microbiological Effects of Constipation Treatment in Patients with Chronic Kidney Disease: A Pilot Feasibility Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $887,206 | August 11, 2023 | July 31, 2027 | KOVESDY, CSABA PAL | reporter.nih.gov |
| Regulation of mechanosensitive ion channels by membrane lipids | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $886,161 | August 1, 2019 | August 31, 2023 | VASQUEZ, VALERIA | reporter.nih.gov |
| Predictive Modeling of Influenza-Pneumococcal Coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $885,870 | July 1, 2018 | June 30, 2024 | SMITH, AMBER M | reporter.nih.gov |
| Endothelial Vasoprotection by Hypothermia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $848,138 | September 15, 2018 | June 30, 2024 | PARFENOVA, HELENA | reporter.nih.gov |
| Hypothalamic oxytocin influence on extended amygdala CRF neurons in alcohol dependence | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2023 | $842,351 | September 20, 2018 | August 31, 2025 | KIRSON, DEAN | reporter.nih.gov |
| Activation of the Oxytocin System by Neuropeptide S to Generate Anxiolysis and Curb Alcohol Drinking | NIH | National Institute on Drug Abuse | 2021 to 2023 | $814,493 | July 1, 2021 | June 30, 2025 | TUNSTALL, BRENDAN | reporter.nih.gov |
| Increasing Recruitment of underrepresented cancer survivors with awareness enhancing interventions (RUN AWEI) | NIH | National Cancer Institute | 2021 to 2022 | $813,603 | April 1, 2020 | March 31, 2024 | MARTIN, MICHELLE Y | reporter.nih.gov |
| Early Communication in Tuberous Sclerosis Complex (TSC) and its Prediction of Autism | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $793,981 | August 1, 2022 | May 31, 2027 | GIPSON, TANJALA TRINETTE | reporter.nih.gov |
| Neuronal mechanisms of cerebellar cognitive function | NIH | National Institute of Mental Health | 2021 to 2022 | $792,692 | April 1, 2018 | December 31, 2023 | HECK, DETLEF H | reporter.nih.gov |
| Regulation of Chlamydial Divisome Assembly | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $782,795 | June 17, 2025 | May 31, 2030 | COX, JOHN VINCENT | reporter.nih.gov |
| Spatial taste coding in mouse gustatory cortex | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2022 | $773,388 | May 1, 2018 | April 30, 2024 | BOUGHTER, JOHN D | reporter.nih.gov |
| Targeting TRPC3 Channels for Epileptic Seizures | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $765,000 | December 1, 2021 | November 30, 2024 | JIANG, JIANXIONG | reporter.nih.gov |
| Genes, Neural Circuits, and Behavior | NIH | National Institute of Mental Health | 2021 to 2022 | $761,674 | June 18, 2019 | April 30, 2024 | KIM, IL HWAN | reporter.nih.gov |
| Targeting Siglec-9/E for therapy of sepsis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $760,000 | June 8, 2018 | May 31, 2024 | CHEN, GUOYUN | reporter.nih.gov |
| Defining the roles of Orai3 channel in cardiomyocytes and cardiomyopathy. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $760,000 | September 1, 2020 | August 31, 2025 | MANCARELLA, SALVATORE | reporter.nih.gov |
| Development of Microbiome-Sparing Antibacterials for Clostridioides difficile Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $754,446 | December 4, 2024 | November 30, 2029 | HEVENER, KIRK EDWARD | reporter.nih.gov |
| EP2 Antagonists for Ischemic Stroke | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $752,070 | August 15, 2023 | July 31, 2025 | JIANG, JIANXIONG | reporter.nih.gov |
| Overall NIDA Core "Center of Excellence" in Transcriptomics, Systems Genetics and the Addictome | NIH | National Institute on Drug Abuse | 2021 | $744,955 | August 1, 2017 | May 31, 2024 | WILLIAMS, ROBERT W. | reporter.nih.gov |
| CO2 inhalation enhances the lability of fear memory | NIH | National Institute of Mental Health | 2021 to 2022 | $743,892 | May 1, 2020 | April 30, 2024 | DU, JIANYANG | reporter.nih.gov |
| Genetic Modulators of Glaucoma | NIH | National Eye Institute | 2021 to 2022 | $743,284 | February 1, 2011 | January 31, 2024 | JABLONSKI, MONICA M | reporter.nih.gov |
| scaRNA Modified Induced Pluripotent Stem Cell-Derived Cardiomyocytes or Exosomes Therapy for Chronic Ischemic Cardiomyopathy Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $742,400 | January 1, 2019 | November 30, 2023 | JOHNSON, RAJASINGH | reporter.nih.gov |
| Regulation of Lymphangiogenesis by Thrombospondin 1 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $738,752 | February 1, 2022 | January 31, 2026 | SINGLA, BHUPESH | reporter.nih.gov |
| Structure-Based Design of a Broadly Protective Group A Streptococcal Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $729,285 | June 8, 2017 | December 31, 2023 | DALE, JAMES B. | reporter.nih.gov |
| Discovery of Novel Selective Androgen Receptor Degraders (SARDs) for the Treatment of Spinobulbar Muscular Atrophy (SBMA) or Kennedy’s Disease | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $717,521 | December 1, 2023 | November 30, 2028 | NARAYANAN, RAMESH | reporter.nih.gov |
| Mitochondrial Therapy for Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $693,000 | September 22, 2018 | April 30, 2024 | BAJWA, AMANDEEP | reporter.nih.gov |
| Dissecting the contribution of the transcriptional regulators of SNS fate to neuroblastoma oncogenesis | NIH | National Cancer Institute | 2021 to 2022 | $688,446 | June 1, 2018 | May 31, 2024 | FREEMAN, KEVIN W. | reporter.nih.gov |
| Validation of a novel tau clearance mechanism. | NIH | National Institute on Aging | 2025 | $688,273 | June 1, 2022 | May 31, 2027 | LIAO, FRANCESCA-FANG | reporter.nih.gov |
| Mechanisms of Gastrointestinal Post-Inflammatory Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $684,000 | June 1, 2020 | May 31, 2025 | VERNE, GEORGE NICHOLAS | reporter.nih.gov |
| Monocytic and exosomal cytochrome P450s in smoking-mediated HIV-1 pathogenesis | NIH | National Institute on Drug Abuse | 2021 to 2022 | $684,000 | September 30, 2018 | June 30, 2024 | KUMAR, SANTOSH | reporter.nih.gov |
| Genetic modifiers of Sickle Cell Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $682,139 | February 1, 2022 | January 31, 2027 | ZAHR, RIMA | reporter.nih.gov |
| Targeted MDM2 degradation for improved treatment for triple-negative breast cancer | NIH | National Cancer Institute | 2025 | $658,561 | August 7, 2025 | July 31, 2030 | LI, WEI | reporter.nih.gov |
| Skeletal Functions of Polycystins and TAZ | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $655,424 | August 24, 2018 | June 30, 2024 | XIAO, ZHOUSHENG | reporter.nih.gov |
| Social environment determines the hedonice value of nicotine via molecular and cellular networks in the amygdala | NIH | National Institute on Drug Abuse | 2025 | $654,500 | July 15, 2025 | March 31, 2030 | CHEN, HAO | reporter.nih.gov |
| Effects of NPY on Hippocampal Circuit Function | NIH | National Institute of Mental Health | 2024 | $642,885 | May 1, 2024 | April 30, 2026 | DOBRUNZ, LYNN E | reporter.nih.gov |
| Host genetic determinants regulating susceptibility/resistance to SARS-CoV-2 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $629,310 | May 20, 2022 | April 30, 2025 | LI, KUI | reporter.nih.gov |
| Fluorescence Activated Cell Sorter | NIH | Office of the Director, National Institutes of Health | 2023 | $616,949 | August 1, 2023 | July 31, 2024 | MARION, TONY N. | reporter.nih.gov |
| Eosinophils as Effectors of Antibacterial Immunity in the Lungs | NIH | National Heart, Lung, and Blood Institute | 2024 | $615,455 | September 1, 2024 | June 30, 2028 | SAMARASINGHE, AMALI | reporter.nih.gov |
| MicroRNA-based epigenetic approach to induce fetal hemoglobin | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $610,015 | July 13, 2020 | June 30, 2024 | STARLARD-DAVENPORT, ATHENA | reporter.nih.gov |
| The Role of Bioactive Lipids in Transient Receptor Potential Channels Gating | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $608,000 | January 1, 2018 | August 31, 2023 | CORDERO-MORALES, JULIO F | reporter.nih.gov |
| Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis | NIH | National Cancer Institute | 2021 to 2022 | $590,916 | August 1, 2001 | March 31, 2024 | TIGYI, GABOR J | reporter.nih.gov |
| Inhibiting mPGES-1 as a countermeasure to mitigate organophosphate-induced neurotoxicity | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $577,498 | June 19, 2024 | May 31, 2027 | JIANG, JIANXIONG | reporter.nih.gov |
| RSPO2-LGR4 signaling in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $559,893 | January 6, 2025 | November 30, 2029 | SINGLA, BHUPESH | reporter.nih.gov |
| Role of Executive Control in Adolescent Substance Use and Co-occuring Problems | NIH | National Institute on Drug Abuse | 2021 | $551,736 | July 1, 2020 | November 30, 2022 | MASON, W ALEX | reporter.nih.gov |
| Regulation of Mesenchymal Stem Cell Secretome for Treatment of Microglia Damage in Traumatic Brain Injury | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $539,000 | August 3, 2022 | July 31, 2024 | GANGARAJU, RAJASHEKHAR | reporter.nih.gov |
| The Role of Sensory Receptors in Angelman Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $512,103 | February 15, 2023 | August 31, 2023 | CORDERO-MORALES, JULIO F | reporter.nih.gov |
| Broad spectrum antifungals targeting fatty acid biosynthesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $478,000 | December 8, 2016 | November 30, 2023 | PALMER, GLEN | reporter.nih.gov |
| Expanding the small molecule toolbox through novel applications of fluorinated alkenes | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $462,000 | September 1, 2023 | June 30, 2028 | ROY, SUDESHNA | reporter.nih.gov |
| Novel Pharmacological Approach to Stroke Neuroprotection | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $459,111 | January 1, 2025 | December 31, 2029 | LEBECHE, DJAMEL | reporter.nih.gov |
| Extracellular vesicles-based drug delivery of antiretroviral regimen to target CNS HIV reservoirs | NIH | National Institute of Mental Health | 2021 to 2022 | $423,500 | August 1, 2021 | July 31, 2024 | KUMAR, SANTOSH | reporter.nih.gov |
| Novel DNA damage-Based Mechanisms and Therapeutics for Parkinson’s disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $423,500 | August 19, 2022 | July 31, 2025 | KHAN, MOHAMMAD MOSHAHID | reporter.nih.gov |
| Actions of proline at receptors and synapses | NIH | National Institute of Mental Health | 2022 to 2023 | $423,500 | August 1, 2022 | July 31, 2025 | TAVALIN, STEVEN J | reporter.nih.gov |
| Extracellular vesicles in AD-like pathology in HIV and its potential therapeutics | NIH | National Institute on Aging | 2023 to 2024 | $423,500 | March 1, 2023 | February 28, 2026 | KUMAR, SANTOSH | reporter.nih.gov |
| A role of balanced sex hormone in DNA repair in human melanocytes | NIH | National Institute of Environmental Health Sciences | 2023 | $423,500 | July 25, 2023 | June 30, 2025 | LIU-SMITH, FENG | reporter.nih.gov |
| Personalized bioprinting technology for de novo PDL regeneration | NIH | National Institute of Dental & Craniofacial Research | 2023 | $423,500 | September 1, 2023 | August 31, 2025 | HUANG, GEORGE T.J | reporter.nih.gov |
| Genetic Determinants of Aspergillus host-pathogen interactions | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $423,500 | June 23, 2023 | May 31, 2026 | FORTWENDEL, JARROD R. | reporter.nih.gov |
| Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse | NIH | National Institute on Drug Abuse | 2024 | $423,500 | September 15, 2024 | August 31, 2026 | TUNSTALL, BRENDAN | reporter.nih.gov |
| The Ferret as a model for evaluation of antiviral efficacy against Venezuelan equine encephalitis virus | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $423,500 | July 15, 2025 | June 30, 2027 | JONSSON, COLLEEN B | reporter.nih.gov |
| Promoting cognitive screening and assessment post-aneurysmal subarachnoid hemorrhage for better equity in outcomes | NIH | National Institute of Nursing Research | 2024 | $421,188 | June 11, 2024 | May 31, 2026 | STANFILL, ANSLEY | reporter.nih.gov |
| Examining the importance of folate biosynthetic enzymes in infectious fungi | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $418,000 | December 1, 2020 | November 30, 2023 | PALMER, GLEN | reporter.nih.gov |
| Kinetics of neo-vascularization during pulp regeneration | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $418,000 | July 1, 2021 | June 30, 2024 | HUANG, GEORGE T.J | reporter.nih.gov |
| Lipid emulsion composition as a determinant of fungal biofilm formation and incidence of candidemia | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $418,000 | April 9, 2021 | March 31, 2024 | PETERS, BRIAN M | reporter.nih.gov |
| Targeting defective spliceosomal pathway in myeloid malignancies | NIH | National Cancer Institute | 2022 to 2023 | $410,690 | April 1, 2022 | March 31, 2025 | YANG, CHAO-YIE | reporter.nih.gov |
| Exploring Margaric Acid Role in Alcohol-Associated Liver Diseases | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $404,250 | September 23, 2025 | August 31, 2027 | RAO, RADHAKRISHNA | reporter.nih.gov |
| Contributions of biopsychosocial factors in sickle cell disease pain | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $402,258 | July 15, 2020 | June 30, 2024 | ROACH, KEESHA L. | reporter.nih.gov |
| The role of enteroendocrine cell differentiation in the success of bariatric surgery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $402,075 | September 1, 2021 | August 31, 2026 | KIM, KI SUK | reporter.nih.gov |
| Repurposing FDA-Approved Drugs to Target Chronic Alcohol Tolerance | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $399,076 | September 15, 2025 | August 31, 2027 | JEE, CHANG HOON | reporter.nih.gov |
| Identification of luteolin as a BRAF-degrading molecule for developing new therapeutic agents | NIH | National Cancer Institute | 2022 to 2023 | $392,374 | January 1, 2022 | December 31, 2024 | LIU-SMITH, FENG | reporter.nih.gov |
| The neuroimmune mechanism of SARS-CoV-2 on synaptic transmission and plasticity | NIH | National Institute of Mental Health | 2025 | $384,772 | January 10, 2025 | November 30, 2028 | DU, JIANYANG | reporter.nih.gov |
| Eosinophils as Regulators of Host Immunity against Influenza Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $380,000 | March 6, 2017 | August 31, 2022 | SAMARASINGHE, AMALI | reporter.nih.gov |
| Muscle GPRC6A regulation of protein turnover with overload and disuse recovery | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $372,680 | June 1, 2022 | May 31, 2025 | ALWAY, STEPHEN E | reporter.nih.gov |
| Targeting Diabetes With Novel SERCA Allosteric Activators | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $346,500 | February 16, 2022 | June 30, 2024 | LEBECHE, DJAMEL | reporter.nih.gov |
| Targeting TRPC3 Channels for Epileptic Seizures | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $346,500 | December 1, 2021 | November 30, 2025 | JIANG, JIANXIONG | reporter.nih.gov |
| Mechanisms of retinal angiogenesis | NIH | National Eye Institute | 2021 | $331,740 | June 1, 2006 | March 31, 2023 | RAO, GADIPARTHI N | reporter.nih.gov |
| Inhibitory Receptors and Autoimmune Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $324,368 | May 13, 2016 | April 30, 2024 | YI, AE-KYUNG | reporter.nih.gov |
| Modernization of the UTHSC Animal Care Facility | NIH | Office of the Director, National Institutes of Health | 2022 | $320,468 | July 1, 2022 | June 30, 2023 | HAMILTON, DAVID JOHN | reporter.nih.gov |
| Understanding Social Communication Abilities in Individuals with Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $319,460 | April 15, 2021 | January 31, 2025 | HARKRIDER, ASHLEY W | reporter.nih.gov |
| Functional genetic analysis of epigenetic age acceleration and the regulatory landscape of the methylome | NIH | National Institute on Aging | 2022 | $315,415 | September 1, 2022 | August 31, 2024 | MOZHUI, KHYOBENI | reporter.nih.gov |
| Development of a novel gene therapy for the treatment of tauopathy | NIH | National Institute on Aging | 2022 | $308,000 | July 15, 2022 | June 30, 2025 | KHAN, MOHAMMAD MOSHAHID | reporter.nih.gov |
| 9/22 Limited Competition for Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $296,181 | August 20, 1994 | January 31, 2023 | DAGOGO-JACK, M.D., D.SC., SAMUEL | reporter.nih.gov |
| Improved Glaucoma Monitoring Using Artificial-Intelligence Enabled Dashboard | NIH | National Eye Institute | 2021 to 2022 | $291,826 | September 1, 2022 | August 31, 2023 | YOUSEFI, SIAMAK | reporter.nih.gov |
| Cryptococcal Chitin Synthase 3 and Host Immune Responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $270,000 | September 1, 2021 | July 31, 2024 | HOLE, CAMARON REYNOLDS | reporter.nih.gov |
| Feasibility of novel Fluorine Non-thermal plasma for dental caries control | NIH | National Institute of Dental & Craniofacial Research | 2023 to 2024 | $254,618 | August 1, 2023 | July 31, 2025 | HONG, LIANG | reporter.nih.gov |
| Trauma induced endothelial cell Ca2+ signaling | NIH | National Heart, Lung, and Blood Institute | 2021 | $249,000 | September 15, 2016 | June 30, 2023 | COLLIER, DANIEL MOHR | reporter.nih.gov |
| A novel circuit underlying amotivation in a mouse model of 22q11DS | NIH | National Institute of Mental Health | 2025 | $249,000 | December 12, 2022 | May 31, 2028 | PATTON, MARY H. | reporter.nih.gov |
| Modeling Host-Fungal Interactions in Hirschsprung-Associated Enterocolitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $241,108 | June 9, 2021 | December 16, 2022 | GOSAIN, ANKUSH | reporter.nih.gov |
| A generalizable deep learning platform for unifying quantification of experimental autoimmune uveitis | NIH | National Eye Institute | 2025 | $231,000 | February 1, 2025 | August 4, 2025 | YOUSEFI, SIAMAK | reporter.nih.gov |
| Predicting Outcomes in Children with Ulcerative Colitis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $218,481 | July 8, 2021 | December 31, 2024 | WANG, ZHU | reporter.nih.gov |
| Evaluation of the synergistic effects of developmental and adult alcohol exposure on Alzheimer's-related phenotypes | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $188,313 | September 26, 2025 | August 31, 2027 | HAMRE, KRISTIN M | reporter.nih.gov |
| Pan-cancer genomic characterization of human papillomavirus associated tumors | NIH | National Cancer Institute | 2022 to 2025 | $185,946 | May 1, 2022 | April 30, 2026 | HOLT, JEREMIAH R. | reporter.nih.gov |
| Identifying a transcriptional core regulatory circuitry and other critical transcription factor dependencies in H3.3 G34R/V high-grade glioma | NIH | National Cancer Institute | 2022 to 2025 | $185,698 | April 1, 2022 | March 31, 2027 | ROACH, JORDAN TRENT | reporter.nih.gov |
| Development of chimeric antigen receptor-expressing macrophages for enhanced phagocytosis of systemic amyloid | NIH | National Institute on Aging | 2021 | $175,000 | September 30, 2020 | May 31, 2022 | WALL, JONATHAN S | reporter.nih.gov |
| Graduate Research Fellowship Program (GRFP) | NSF | Scholarships, Fellowships, and Traineeships Section | 2024 | $159,000 | September 1, 2024 | August 31, 2029 | Max Fletcher | nsf.gov |
| Identification and characterization of the gene associated with the spontaneous autosomal recessive Spinning mice | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $154,000 | May 15, 2021 | November 30, 2023 | XIAO, JIANFENG | reporter.nih.gov |
| Function of a novel Mycobacterium tuberculosis lipase and its interaction with host proteins | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $154,000 | August 19, 2022 | July 31, 2025 | KONG, YING | reporter.nih.gov |
| Sensory Ion Channel Modulation by Bioactive Lipids | NIH | National Institute of General Medical Sciences | 2023 | $109,836 | April 1, 2023 | August 31, 2023 | CORDERO-MORALES, JULIO F | reporter.nih.gov |
| The role of bile acids to ameliorate obesity driven triple negative breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $79,670 | August 4, 2021 | August 15, 2022 | SIPE, LAURA MARIE | reporter.nih.gov |
| Cholesterol modulation of BK currents and cerebral artery diameter via channel-forming slo1 subunits | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $78,928 | August 1, 2023 | July 31, 2025 | SCHNEIDER, ELIZABETH HOPE | reporter.nih.gov |
| Modulating drug efflux transporter expression on the macrophage reservoir of HIV | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $77,000 | August 1, 2025 | July 31, 2027 | CORY, THEODORE | reporter.nih.gov |
| Fatty acid and alcohol modulation of cerebral artery diameter | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 | $76,000 | May 1, 2020 | April 30, 2022 | BUKIYA, ANNA | reporter.nih.gov |
| Pregnenolone constricts cerebral vascular arteries through the direct modulation of BK ion channels | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $67,260 | August 1, 2021 | April 10, 2023 | NORTH, KELSEY CLELAND | reporter.nih.gov |
| Short Term Research Training for Medical Students | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $55,595 | July 1, 2017 | July 31, 2022 | DAGOGO-JACK, M.D., D.SC., SAMUEL | reporter.nih.gov |
| Interrogation of SidB-dependent septation for echinocandin potentiation in invasive aspergillosis treatment | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $40,960 | April 15, 2025 | April 14, 2027 | THORN, HARRISON IGNATZ | reporter.nih.gov |
| PKC agonism restricts innate immune suppression and promotes antigen cross-presentation in Triple Negative Breast Cancer | NIH | National Cancer Institute | 2022 | $32,848 | December 20, 2021 | August 31, 2022 | CHAIB, MEHDI | reporter.nih.gov |
| Manipulation of the gut microbiome to delay breast cancer onset and progression in the context of weight loss and obesity | NIH | National Cancer Institute | 2025 | $29,283 | May 28, 2025 | December 5, 2025 | BOHM, MARGARET SUE | reporter.nih.gov |
| Pre-Clinical Models of Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,500 | July 15, 2024 | July 14, 2031 | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $53,000 |
| 2025 | 83 | $50,036,725 | 1 | $53,000 |
| 2024 | 89 | $45,567,611 | 1 | $53,000 |
| 2023 | 107 | $53,829,649 | 0 | $0 |
| 2022 | 125 | $61,519,968 | 0 | $0 |
| 2021 | 105 | $58,362,493 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 31 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 31 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 31 awards here |
Topics of its NIH awards
- Neurosciences
- Genetics
- Brain Disorders
- Biotechnology
- Prevention
- Behavioral and Social Science
- Clinical Research
- Infectious Diseases
- Neurodegenerative
- Aging
- Nutrition
- Rare Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.